Target intelligence / Profile preview

Glutamate receptor ionotropic AMPA type subunit 1 (GluA1) and Glutamate receptor ionotropic AMPA type subunit 2 (GluA2) (GluA1 and GluA2)

Target
GluA1 and GluA2
Molecular classification
Receptor, Ion channel, Ligand-gated ion channel, AMPA receptor subunit, Ionotropic glutamate receptor
01

Overview

Glutamate receptor ionotropic AMPA type subunit 1 (GluA1) and subunit 2 (GluA2) are principal subunits of the AMPA-type ionotropic glutamate receptor, which is a ligand-gated cation channel responsible for fast excitatory synaptic transmission in the mammalian central nervous system. These receptors are tetrameric complexes typically consisting of combinations of GluA1–4 subunits. GluA1 and GluA2 are the most prevalent and functionally significant in synaptic plasticity, memory, learning, and several neuropathologies. Upon glutamate binding, AMPA receptors open to allow sodium and, depending on subunit composition, calcium influx, resulting in neuronal depolarization. Abnormal function or expression is implicated in a variety of neurological and neuropsychiatric disorders.

Other names
Glutamate receptor 1AMPA receptor subunit GluA1GluR1glutamate ionotropic receptor AMPA type subunit 1GRIA1Glutamate receptor 2AMPA receptor subunit GluA2GluR2glutamate ionotropic receptor AMPA type subunit 2GRIA2
02

Mechanism of action

Antagonism of glutamate binding (competitive/non-competitive antagonists) - Inhibition of cation conductance through receptor-associated ion channel - Reduction of excitatory neurotransmission - Allosteric modulation

03

Biological functions

Signal transductionFast excitatory synaptic transmissionRegulation of synaptic plasticity (including long-term potentiation and depression)Learning and memory processesCentral nervous system development and plasticity
04

Disease associations

Neurodegenerative diseaseEpilepsyIschemic brain injury and strokePsychiatric disorders (e.g., schizophrenia, depression)Cognitive impairmentOther neurological diseases
05

Safety considerations

CNS depression (sedation, cognitive impairment)Risk of psychiatric adverse effectsPotential interference with normal synaptic transmission, learning, and memorySeizure risk (with excessive inhibition)
06

Interacting drugs

Perampanel

4 more in the full profile.

07

Biomarkers

Changes in AMPA receptor subunit expression (especially GluA1, GluA2) in cerebrospinal fluid or tissue as an indicator of neurodegeneration or synaptic functionAltered phosphorylation states of GluA1

Beyond the preview

Go deeper on Glutamate receptor ionotropic AMPA type subunit 1 (GluA1) and Glutamate receptor ionotropic AMPA type subunit 2 (GluA2) (GluA1 and GluA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate receptor ionotropic AMPA type subunit 1 (GluA1) and Glutamate receptor ionotropic AMPA type subunit 2 (GluA2) (GluA1 and GluA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call